Olema Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Logos Global Management LP Amends Stake in Olema Pharmaceuticals, Drops Below 5% Ownership Due to Share Dilution
Logos Global Management LP and affiliated entities have filed an amended Schedule 13D for Olema Pharmaceuticals, Inc., reporting a decrease in their beneficial ownership to 4.7% due to an increase in the Issuer's outstanding shares, while maintaining their investment for strategic purposes.